These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32966770)

  • 21. CRISPR Causes Unexpected Genomic Damage.
    Cancer Discov; 2018 Sep; 8(9):OF2. PubMed ID: 30093504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
    Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
    ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR Cas System: An efficient tool for cancer modelling.
    Akhtar M; Jamal T; Khan M; Khan SR; Haider S; Jalil F
    J Pak Med Assoc; 2021 Feb; 71(2(B)):718-724. PubMed ID: 33941966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
    Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
    Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 27. A Genome-Wide CRISPR-Cas9 Loss-of-Function Screening to Identify Host Restriction Factors Modulating Oncolytic Virotherapy.
    Muscolini M; Hiscott J; Tassone E
    Methods Mol Biol; 2023; 2589():379-399. PubMed ID: 36255638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. World Health Organization panel weighs in on CRISPR-babies debate.
    Reardon S
    Nature; 2019 Mar; 567(7749):444-445. PubMed ID: 30914808
    [No Abstract]   [Full Text] [Related]  

  • 29. Clustered Regularly Interspaced Short Palindromic Repeats System of Genome Engineering in Embryos to Repair Genes.
    Niazvand F; Fathinezhad Z; Alfuraiji N; Etajuri EA; Amini-Chermahini F; Chehelgerdi M; Ranjbar R
    J Biomed Nanotechnol; 2021 Mar; 17(3):331-356. PubMed ID: 33875070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient CRISPR/Cas9-based plant genomic fragment deletions by microhomology-mediated end joining.
    Tan J; Zhao Y; Wang B; Hao Y; Wang Y; Li Y; Luo W; Zong W; Li G; Chen S; Ma K; Xie X; Chen L; Liu YG; Zhu Q
    Plant Biotechnol J; 2020 Nov; 18(11):2161-2163. PubMed ID: 32336015
    [No Abstract]   [Full Text] [Related]  

  • 31. From CRISPR scissors to virus sensors.
    Kocak DD; Gersbach CA
    Nature; 2018 May; 557(7704):168-169. PubMed ID: 29730672
    [No Abstract]   [Full Text] [Related]  

  • 32. CRISPR-TSKO: A Tool for Tissue-Specific Genome Editing in Plants.
    Ali Z; Mahfouz MM; Mansoor S
    Trends Plant Sci; 2020 Feb; 25(2):123-126. PubMed ID: 31859038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR technology: The engine that drives cancer therapy.
    Zhang M; Eshraghian EA; Jammal OA; Zhang Z; Zhu X
    Biomed Pharmacother; 2021 Jan; 133():111007. PubMed ID: 33227699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. License CRISPR patents for free to share gene editing globally.
    Nature; 2021 Sep; 597(7875):152. PubMed ID: 34493846
    [No Abstract]   [Full Text] [Related]  

  • 35. [Preface for genome editing special issue].
    Gu F; Gao C
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1661-1664. PubMed ID: 29082714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome editing: The efficient tool CRISPR-Cpf1.
    Mahfouz MM
    Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
    [No Abstract]   [Full Text] [Related]  

  • 37. CRISPR tool modifies genes precisely by copying RNA into the genome.
    Platt RJ
    Nature; 2019 Dec; 576(7785):48-49. PubMed ID: 31792413
    [No Abstract]   [Full Text] [Related]  

  • 38. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
    Zhang X; Cheng C; Sun W; Wang H
    Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas in its prime.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene Editing for the Heart: Correcting Dystrophin Mutations.
    McNally EM
    Circ Res; 2017 Sep; 121(8):896-898. PubMed ID: 28963182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.